# | Title | Journal | Year | Citations |
---|
1 | Systematic Review of Prospective Cohort Studies of Psychosocial Factors in the Etiology and Prognosis of Coronary Heart Disease | Seminars in Vascular Medicine | 2002 | 316 |
2 | Homocysteine: Overview of Biochemistry, Molecular Biology, and Role in Disease Processes | Seminars in Vascular Medicine | 2005 | 133 |
3 | Cost-Effectiveness Analysis of the Genetic Screening Program for Familial Hypercholesterolemia in the Netherlands | Seminars in Vascular Medicine | 2004 | 122 |
4 | Advanced Method for the Identification of Patients with Inherited Hypercholesterolemia | Seminars in Vascular Medicine | 2004 | 101 |
5 | Role of Platelets in the Pathophysiology of Acute Coronary Syndrome | Seminars in Vascular Medicine | 2003 | 98 |
6 | Warfarin and Other Coumarin Derivatives: Pharmacokinetics, Pharmacodynamics, and Drug Interactions | Seminars in Vascular Medicine | 2003 | 93 |
7 | P2Y12, A New Platelet ADP Receptor, Target of Clopidogrel | Seminars in Vascular Medicine | 2003 | 93 |
8 | Epidemiology of Obesity | Seminars in Vascular Medicine | 2005 | 92 |
9 | Application of Molecular Genetics for Diagnosing Familial Hypercholesterolemia in Norway: Results from a Family-Based Screening Program | Seminars in Vascular Medicine | 2004 | 88 |
10 | Human Leptin: An Adipocyte Hormone with Weight-Regulatory and Endocrine Functions | Seminars in Vascular Medicine | 2005 | 85 |
11 | Adipocytokines and Metabolic Syndrome | Seminars in Vascular Medicine | 2005 | 85 |
12 | Epidemiology of Venous Thromboembolism | Seminars in Vascular Medicine | 2001 | 79 |
13 | Aspirin and Other Cyclooxygenase Inhibitors: New Therapeutic Insights | Seminars in Vascular Medicine | 2003 | 75 |
14 | Genetic Determinants of Plasma Total Homocysteine | Seminars in Vascular Medicine | 2005 | 70 |
15 | Effect of Drugs on Homocysteine Concentrations | Seminars in Vascular Medicine | 2005 | 66 |
16 | Fibrin D-Dimer and Cardiovascular Risk | Seminars in Vascular Medicine | 2005 | 63 |
17 | The Role of Dietary Fat in Obesity | Seminars in Vascular Medicine | 2005 | 63 |
18 | Obesity and Cardiovascular Disease: Pathogenic Mechanisms and Potential Benefits of Weight Reduction | Seminars in Vascular Medicine | 2005 | 61 |
19 | Cerebrovascular Risk Factors and Clinical Classification of Strokes | Seminars in Vascular Medicine | 2004 | 60 |
20 | Blood Pressure and Coronary Heart Disease: A Review of the Evidence | Seminars in Vascular Medicine | 2002 | 56 |
21 | Dietary Determinants of Plasma Homocysteine Concentrations | Seminars in Vascular Medicine | 2005 | 56 |
22 | Effects of Statins on Endothelium and Endothelial Progenitor Cell Recruitment | Seminars in Vascular Medicine | 2004 | 55 |
23 | Low-Density Lipoprotein Receptor-Its Structure, Function, and Mutations | Seminars in Vascular Medicine | 2004 | 55 |
24 | The Complex Role of Triglycerides in Cardiovascular Disease | Seminars in Vascular Medicine | 2002 | 54 |
25 | Venous and Arterial Thrombosis during Oral Contraceptive Use: Risks and Risk Factors | Seminars in Vascular Medicine | 2003 | 54 |
26 | Cholesterol, Coronary Heart Disease and Stroke: A Review of Published Evidence from Observational Studies and Randomized Controlled Trials | Seminars in Vascular Medicine | 2002 | 53 |
27 | Familial Hypercholesterolemia in Spain: Case-Finding Program, Clinical and Genetic Aspects | Seminars in Vascular Medicine | 2004 | 53 |
28 | Hemostatic and Rheological Variables and Risk of Cardiovascular Disease | Seminars in Vascular Medicine | 2002 | 52 |
29 | Apolipoprotein E and Familial Dysbetalipoproteinemia: Clinical, Biochemical, and Genetic Aspects | Seminars in Vascular Medicine | 2004 | 52 |
30 | Complications of Oral Anticoagulant Therapy: Bleeding and Nonbleeding, Rates and Risk Factors | Seminars in Vascular Medicine | 2003 | 51 |
31 | Homocysteine and Cognitive Function | Seminars in Vascular Medicine | 2005 | 50 |
32 | Validation, Calibration, and Specificity of Quantitative D-Dimer Assays | Seminars in Vascular Medicine | 2005 | 49 |
33 | Venous Thromboembolism in Pediatrics | Seminars in Vascular Medicine | 2001 | 47 |
34 | Changes of Hemostasis Variables during Pregnancy | Seminars in Vascular Medicine | 2003 | 47 |
35 | Visceral Fat as a Determinant of Fibrinolysis and Hemostasis | Seminars in Vascular Medicine | 2005 | 46 |
36 | Physical Activity and Cardiovascular Disease | Seminars in Vascular Medicine | 2002 | 45 |
37 | The Microvasculature in Insulin Resistance and Type 2 Diabetes | Seminars in Vascular Medicine | 2002 | 44 |
38 | Homozygous Familial Hypercholesterolemia and Its Management | Seminars in Vascular Medicine | 2004 | 42 |
39 | Anti-inflammatory Properties of Statins | Seminars in Vascular Medicine | 2004 | 42 |
40 | The Emerging Role of Lipoproteins in Atherogenesis: Beyond LDL Cholesterol | Seminars in Vascular Medicine | 2004 | 41 |
41 | Obesity and Endothelial Dysfunction | Seminars in Vascular Medicine | 2005 | 38 |
42 | Natural History of Venous Thromboembolism | Seminars in Vascular Medicine | 2001 | 37 |
43 | Upper Extremity Deep Vein Thrombosis: Risk Factors, Diagnosis, and Management | Seminars in Vascular Medicine | 2001 | 37 |
44 | A Critical Evaluation of the Role of Lp(a) in Cardiovascular Disease: Can Lp(a) Be Useful in Risk Assessment? | Seminars in Vascular Medicine | 2002 | 37 |
45 | Coronary Heart Disease and Body Mass Index: A Systematic Review of the Evidence from Larger Prospective Cohort Studies | Seminars in Vascular Medicine | 2002 | 36 |
46 | Clinical, Diagnostic, and Therapeutic Aspects of Familial Hypercholesterolemia | Seminars in Vascular Medicine | 2004 | 35 |
47 | The Insulin Resistance Syndrome: Mechanisms of Clustering of Cardiovascular Risk | Seminars in Vascular Medicine | 2002 | 34 |
48 | Optimizing the Efficacy and Safety of Oral Anticoagulant Therapy: High-Quality Dose Management, Anticoagulation Clinics, and Patient Self-Management | Seminars in Vascular Medicine | 2003 | 34 |
49 | The Role of the Somatotropic System in Cognition and Other Cerebral Functions | Seminars in Vascular Medicine | 2004 | 34 |
50 | Homocysteine and Folic Acid: Implications for Pregnancy | Seminars in Vascular Medicine | 2005 | 34 |